UBS Raises PT on Amgen Inc. (AMGN) to $326 From $315, Keeps a Neutral Rating
Amgen Inc. (NASDAQ:AMGN) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, UBS analyst Trung Huynh raised the firm’s price target on…
Share